全球领先的新经济产业第三方数据挖掘与分析机构
关于“上门美业O2O”的报告
艾媒报告 |2018-2019中国医疗美容行业研究与产业链分析报告
本报告研究涉及企业/品牌包括:新氧、更美、悦美、美黛拉、美丽神器、美呗、南方医院、伊美尔、熙朵、碧莲盛、雍禾植发、科发源植发、新生植发、恒博医疗、昊海生物科技、华熙生物、复星医药、深圳鹏爱医疗美容医院、北京丽都医疗美容医院
中国医疗美容行业处于快速发展期,iiMedia Research(艾媒咨询)监测发现,2018年中国医美行业市场规模达2245亿元,牙齿美容及面部美容是医美市场的重要构成部分,占比分别达32.5%和35.3%。目前中国医美行业已形成生产商、医美机构、终端市场三大产业链环节,产业发展前景广阔,但作为新兴行业,中国医疗美容行业将面临着行业监管、公共关系危机、行业竞争激烈等几大风险。
Driven by the rise of the younger generation of consumer groups and the development of new models in the medical beauty industry, the penetration rate and consumer demand of China's medical beauty industry continue to rise. In 2018, the penetration rate of Chinese medical users reached 7.4%, and women were the main medical and aesthetic consumers. The proportion is 88.9%. At present, there are more than 10,000 registered medical and beauty institutions in China, and the industry is in a period of rapid development. iiMedia Research found that embedding, double eyelids, and full body fat filling are the favorite surgical items for Chinese women and medical consumers, while nasal synthesis, tautological fat, cheeks, hair transplants, etc. For the Chinese male medical beauty consumer's favorite surgical project, potential customers in China's medical beauty industry are most concerned about the safety of surgery, followed by medical qualifications and word of mouth and surgery prices. Medical beauty as an emerging industry, public relations crisis, strict industry supervision, lack of relevant professionals is a factor that restricts its development, and in the future, with the influx of capital from the industry, the competition in China's medical and aesthetic industry will become more intense.艾媒咨询 | 2024年中国家政行业发展状况与消费者行为数据分析报告
随着社会经济不断发展、三孩生育政策实施以及人口老龄化程度加快,家政服务业市场需求日益增长,行业服务细分凸显,新技术新模式的结合日益紧密。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024年中国家政行业发展状况与消费者行为数据分析报告》数据显示,2015-2027年间中国家政服务市场规模呈现整体上升趋势。2023年中国家政服务市场达到11641万元,预计2027年达到13855万元。这一情况反映了中国家政服务市场中需求量不断增加。
艾媒咨询分析师认为,随着中国社会老龄化的逐步加深,中国家政行业将迎来更广阔的市场。
With the continuous development of social economy, the implementation of the three-child policy and the acceleration of population aging, the market demand for domestic service industry is growing day by day, the industry service segmentation is highlighted, and the combination of new technologies and new models is becoming closer. According to the latest "2024 China Domestic Service Industry Development Status and Consumer Behavior Data Analysis Report" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the size of China's domestic service market shows an overall upward trend from 2015 to 2027. In 2023, China's domestic service market reached 116.41 million yuan, and is expected to reach 138.55 million yuan in 2027. This situation reflects the increasing demand in China's domestic service market.
Analysts from iiMedia Consulting believe that with the gradual deepening of China's aging society, China's domestic industry will usher in a broader market.艾媒咨询 | 2025-2026年中国本地生活服务市场竞争格局和消费调查研究报告
作为连接日常消费与商业服务的核心赛道,中国本地生活服务市场近年受消费升级、技术赋能驱动,正从“规模增长”转向“场景深耕”。近期高德推出“扫街榜”,聚焦线下特色小店,反映行业对“精准匹配消费需求”的探索。iiMedia Research(艾媒咨询)数据显示,2025年中国O2O市场规模将达38881.0亿元,同比增长17.6%,预计2028年将达59144.1亿元。
As a core track connecting daily consumption and commercial services, the local life service market in China has been driven by consumption upgrade and technological empowerment in recent years, shifting from "scale growth" to "in-depth scene cultivation". Recently, Autonavi launched the "Street Sweeping List", focusing on offline characteristic small stores, reflecting the industry's exploration of "precisely matching consumer demands". iiMedia Research data shows that the scale of China's O2O market will reach 3,888.1 billion yuan in 2025, with a year-on-year growth of 17.6%. It is expected to reach 5,914.41 billion yuan in 2028.艾媒咨询|2021全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:阿里健康,美团,京东健康,叮当快药,1药网,Walgreens,百度健康,药材买卖网,中药材天地网,找药网,九州通,药易购,珍诚医药在线,CVS
在政策利好、互联网技术等多重因素推动下,中国医药电商行业规模持续快速发展,2020年中国医药电商市场交易规模达到1956亿元。当前,中药电商商业模式主要为B2B、B2C、O2O与DTP四种类型,其中,2020年,医药电商B2C模式占比近6%,市场规模为116亿元;医药电商B2C模式占比近84%,市场规模为1640亿元,成为当前的主流。此外,近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,而DTP药房模式下,患者在医院开取处方后,药房根据处方以患者或家属指定的时间和地点送药上门,被称为高值新特药直送平台。
Driven by favorable policies, Internet technology and other factors, the scale of China's pharmaceutical e-commerce industry continues to develop rapidly, with the transaction scale of China's pharmaceutical e-commerce market reaching 1956 billion yuan in 2020. At present, the business models of traditional Chinese medicine e-commerce are mainly B2B, B2C, o2o and DTP. In 2020, the B2C model of pharmaceutical e-commerce accounts for nearly 6% and the market scale is 11.6 billion yuan; the B2C model of pharmaceutical e-commerce accounts for nearly 84% and the market scale is 164 billion yuan, which has become the current mainstream. In addition, the o2o mode, which has sprung up in recent years, mainly achieves profits through "drainage transformation consumption feedback". In the DTP pharmacy mode, after patients get prescriptions in the hospital, the pharmacy delivers drugs to the door at the time and place designated by the patients or their families according to the prescriptions, which is known as the high value new special drugs direct delivery platform.
- 1
- 2
- 3
- 4
- 5
- 6
- 282